https://pipelinereview.com/Arecor-Announces-Positive-Headline-Results-for-the-First-Phase-I-Clinical-Trial-of-AT247-a-Novel-Ultra-Rapid-Acting-Formulation-of-Insulin/
Arecor Announces Positive Headline Results for the First Phase I Clinical Trial of AT247, a Novel Ultra Rapid Acting Formulation of Insulin